A DNA Methylation-Based Test for Breast Cancer Detection in Circulating Cell-Free DNA

Background: Breast cancer (BrC) is the most frequent neoplasm in women. New biomarkers, including aberrant DNA methylation, may improve BrC management. Herein, we evaluated the detection and prognostic performance of seven genes’ promoter methylation (APC, BRCA1, CCND2, FOXA1, PSAT1, RASSF1A and SCG...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Clin Med
Hlavní autoři: Salta, Sofia, P. Nunes, Sandra, Fontes-Sousa, Mário, Lopes, Paula, Freitas, Micaela, Caldas, Margarida, Antunes, Luís, Castro, Fernando, Antunes, Pedro, Palma de Sousa, Susana, Henrique, Rui, Jerónimo, Carmen
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2018
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6262630/
https://ncbi.nlm.nih.gov/pubmed/30405052
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm7110420
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky